logo-loader

Espial shares rise after Mackie's upbeat broker note

Last updated: 15:08 19 May 2016 EDT, First published: 10:08 19 May 2016 EDT

ipad-on-knee
Who is the European customer?

Espial Group (TSE:ESP) shares rose more than 2% on Thursday while most tickers fell, after an upbeat assessment from brokers at Mackie Research.
The stock received a Buy recommendation and the price target is C$4.25.

"We have even more conviction ESP’s first commercial launch of next generation Set Top Boxes (STBs) could come relatively soon," the analysts said.

"First ESP contract deployment is the catalyst investors have been awaiting eagerly. We have previously speculated that ESP’s un-named European customer is NOS Portugal," it added.

Espial shares were up 2.2% at C$2.37 on Thursday.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

18 minutes ago